Platelet reactivity and intramyocardial hemorrhage in patients with ST-segment elevation myocardial infarction

Clinical and Applied Thrombosis/Hemostasis

Volumn 20, Issue 5, 2014, Pages 553-558

  Małek, Łukasz A ^a   Kłopotowski, Mariusz ^a   Śpiewak, Mateusz ^a   Woźniak, Karolina ^a   Waś, Joanna ^a   Miśko, Jolanta ^a   Ruzyłło, Witold ^a   Witkowski, Adam ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

cardiovascular magnetic resonance; intramyocardial hemorrhage; myocardial infarction; platelet reactivity; ST segment elevation

Indexed keywords

COLLAGEN; RISTOCETIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HEART MUSCLE REPERFUSION; HUMAN; INTRAMYOCARDIAL HEMORRHAGE; MALE; MYOCARDIAL DISEASE; NUCLEAR MAGNETIC RESONANCE SCANNER; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOCYTE AGGREGATION; AGED; BLEEDING; BLOOD; BLOOD CLOTTING PARAMETERS; CLINICAL TRIAL; HEART MUSCLE; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RADIOGRAPHY; THROMBOCYTE; THROMBOCYTE ACTIVATION;

AGED; BLOOD PLATELETS; FEMALE; HEMORRHAGE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; PERCUTANEOUS CORONARY INTERVENTION; PLATELET ACTIVATION; PLATELET FUNCTION TESTS;

EID: 84901719552     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029612474715     Document Type: Article

References (20)

1. Ito H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat Clin Pract Cardiovasc Med. 2006 ; 3 (9). 499-506
2. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007 ; 357 (11). 1121-1135
3. Hombach V, Grebe O, Merkle N, et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J. 2005 ; 26 (6). 549-557
4. Ganame J, Messalli G, Dymarkowski S, et al. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Eur Heart J. 2009 ; 30 (12). 1440-1449
5. Eitel I, Kubusch K, Strohm O, et al. Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction. Circ Cardiovasc Imaging. 2011 ; 4: 354-362
6. Amabile N, Jacquier A, Shuhab A, et al. Incidence, predictors, and prognostic value of intramyocardial hemorrhage lesions in ST elevation myocardial infarction. Catheter Cardiovasc Interv. 2011 ; 79 ((7)). 1101-1108
7. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European society of cardiology. Eur Heart J. 2008 ; 29 (23). 2909-2945
8. Moscucci M, Fox KA, Cannon CP, et al. Predictors of major bleeding in acute coronary syndromes: the global registry of acute coronary events (GRACE). Eur Heart J. 2003 ; 24 (20). 1815-1823
9. Mehran R, Lansky AJ, Witzenbichler B, et al. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet. 2009 ; 374 (9696). 1149-1159
10. Toth O, Calatzis A, Penz S, et al. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost. 2006 ; 96 (6). 781-788
11. Larose E, Rodes-Cabau J, Pibarot P, et al. Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2010 ; 55 (22). 2459-2469
12. De Luca G, Suryapranata H, Stone GW, et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA. 2005 ; 293 (14). 1759-1765
13. Montalescot G, Antoniucci D, Kastrati A, et al. Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up. Eur Heart J. 2007 ; 28 (4). 443-449
14. Kastrati A, Mehilli J, Schühlen H, et al. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med. 2004 ; 350 (3). 232-238
15. Mehilli J, Kastrati A, Schulz S, et al. Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading. A randomized double-blind trial. Circulation. 2009 ; 119 (14). 1933-1940
16. Witkowski A, Maciejewski P, Wasek W, et al. Influence of different antiplatelet treatment regimens for primary percutaneous coronary intervention on all-cause mortality. Eur Heart J. 2009 ; 30 ((14)). 1736-1743
17. De Luca G, Navarese E, Marino P. Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials. Eur Heart J. 2009 ; 30 ((22)). 2705-2713
18. Kim HW, Farzaneh-Far A, Kim RJ. Cardiovascular magnetic resonance in patients with myocardial infarction. Current and emerging applications. J Am Coll Cardiol. 2010 ; 55: 1-16
19. Lockie T, Nagel E, Redwood S, Plein S. Use of cardiovascular magnetic resonance imaging in acute coronary syndromes. Circulation. 2009 ; 119 (12). 1671-1681
20. Basso C, Corbetti F, Silva C, et al. Morphologic validation of reperfused hemorrhagic myocardial infarction by cardiovascular magnetic resonance. Am J Cardiol. 2007 ; 100 (8). 1322-1327